Xolair 75 MG/0.5 ML autoinject 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FX1LH
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,703
Award facts
- Contract value 100% obligated
- $1,702.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,702.68 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 75 mg/0.5 mL autoinjector units. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of December 3, 2025, and was issued without a set-aside designation. This award was funded by the Defense Logistics Agency and represents a single transaction under the company's broader pharmaceutical supply relationship with the federal government.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to streamline pharmaceutical supply chains for the Department of Defense. The underlying IDC, valued at $499,999,999 with a completion date of December 31, 2036, authorizes DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceuticals and medical consumables to support military healthcare facilities worldwide. DMS Pharmaceutical Group's demonstrated performance across numerous delivery orders for diverse specialty pharmaceuticals and biologics positions the company as a critical supplier within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DB26FX1LH?
SPE2DB26FX1LH was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 10, 2025.
How much is contract SPE2DB26FX1LH worth?
The government has obligated $1,703 on SPE2DB26FX1LH.
Is contract SPE2DB26FX1LH an order under another contract?
Yes. SPE2DB26FX1LH is a delivery order under SPE2DB22D9353, an indefinite delivery contract.
Was contract SPE2DB26FX1LH competed?
The extent of competition for SPE2DB26FX1LH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award